These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25100502)

  • 1. Design and synthesis of sulfamoyl benzoic acid analogues with subnanomolar agonist activity specific to the LPA2 receptor.
    Patil R; Fells JI; Szabó E; Lim KG; Norman DD; Balogh A; Patil S; Strobos J; Miller DD; Tigyi GJ
    J Med Chem; 2014 Aug; 57(16):7136-40. PubMed ID: 25100502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The LPA
    Kuo B; Szabó E; Lee SC; Balogh A; Norman D; Inoue A; Ono Y; Aoki J; Tigyi G
    Cell Signal; 2018 Nov; 51():23-33. PubMed ID: 30063964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysophosphatidic acid type 2 receptor agonists in targeted drug development offer broad therapeutic potential.
    Tigyi GJ; Johnson LR; Lee SC; Norman DD; Szabo E; Balogh A; Thompson K; Boler A; McCool WS
    J Lipid Res; 2019 Mar; 60(3):464-474. PubMed ID: 30692142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virtual screening for LPA2-specific agonists identifies a nonlipid compound with antiapoptotic actions.
    Kiss GN; Fells JI; Gupte R; Lee SC; Liu J; Nusser N; Lim KG; Ray RM; Lin FT; Parrill AL; Sümegi B; Miller DD; Tigyi G
    Mol Pharmacol; 2012 Dec; 82(6):1162-73. PubMed ID: 22968304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysophosphatidic Acid Receptor Agonism: Discovery of Potent Nonlipid Benzofuran Ethanolamine Structures.
    Guillot E; Le Bail JC; Paul P; Fourgous V; Briand P; Partiseti M; Cornet B; Janiak P; Philippo C
    J Pharmacol Exp Ther; 2020 Aug; 374(2):283-294. PubMed ID: 32409422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorothioate analogues of alkyl lysophosphatidic acid as LPA3 receptor-selective agonists.
    Qian L; Xu Y; Simper T; Jiang G; Aoki J; Umezu-Goto M; Arai H; Yu S; Mills GB; Tsukahara R; Makarova N; Fujiwara Y; Tigyi G; Prestwich GD
    ChemMedChem; 2006 Mar; 1(3):376-83. PubMed ID: 16892372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural insights into PDZ-mediated interaction of NHERF2 and LPA(2), a cellular event implicated in CFTR channel regulation.
    Holcomb J; Jiang Y; Lu G; Trescott L; Brunzelle J; Sirinupong N; Li C; Naren AP; Yang Z
    Biochem Biophys Res Commun; 2014 Mar; 446(1):399-403. PubMed ID: 24613836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of functional human lysophosphatidic acid receptor 2 using a P9
    Han SG; Baek SI; Son TJ; Lee H; Kim NH; Yu YG
    Biochem Biophys Res Commun; 2017 May; 487(1):103-108. PubMed ID: 28392399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Edg-Like LPA Receptor-Ligand Interactions.
    Balogh B; Pazmany T; Matyus P
    Curr Pharm Des; 2015; 21(24):3533-47. PubMed ID: 25686617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the LPA2 receptor signaling through the carboxyl-terminal tail-mediated protein-protein interactions.
    Lin FT; Lai YJ
    Biochim Biophys Acta; 2008 Sep; 1781(9):558-62. PubMed ID: 18501721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined mitigation of the gastrointestinal and hematopoietic acute radiation syndromes by an LPA2 receptor-specific nonlipid agonist.
    Patil R; Szabó E; Fells JI; Balogh A; Lim KG; Fujiwara Y; Norman DD; Lee SC; Balazs L; Thomas F; Patil S; Emmons-Thompson K; Boler A; Strobos J; McCool SW; Yates CR; Stabenow J; Byrne GI; Miller DD; Tigyi GJ
    Chem Biol; 2015 Feb; 22(2):206-16. PubMed ID: 25619933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of phosphonic and thiophosphoric acid derivatives of lysophosphatidic acid.
    Santos WL; Heasley BH; Jarosz R; Carter KM; Lynch KR; Macdonald TL
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3473-6. PubMed ID: 15177455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alkoxymethylenephosphonate analogues of (Lyso) phosphatidic acid stimulate signaling networks coupled to the LPA2 receptor.
    Gajewiak J; Tsukahara R; Tsukahara T; Fujiwara Y; Yu S; Lu Y; Murph M; Mills GB; Tigyi G; Prestwich GD
    ChemMedChem; 2007 Dec; 2(12):1789-98. PubMed ID: 17952880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LPA2 receptor mediates mitogenic signals in human colon cancer cells.
    Yun CC; Sun H; Wang D; Rusovici R; Castleberry A; Hall RA; Shim H
    Am J Physiol Cell Physiol; 2005 Jul; 289(1):C2-11. PubMed ID: 15728708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The absence of LPA2 attenuates tumor formation in an experimental model of colitis-associated cancer.
    Lin S; Wang D; Iyer S; Ghaleb AM; Shim H; Yang VW; Chun J; Yun CC
    Gastroenterology; 2009 May; 136(5):1711-20. PubMed ID: 19328876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells.
    Chen M; Towers LN; O'Connor KL
    Am J Physiol Cell Physiol; 2007 May; 292(5):C1927-33. PubMed ID: 17496233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorothioate analogs of sn-2 radyl lysophosphatidic acid (LPA): metabolically stabilized LPA receptor agonists.
    Jiang G; Inoue A; Aoki J; Prestwich GD
    Bioorg Med Chem Lett; 2013 Mar; 23(6):1865-9. PubMed ID: 23395664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Inhibitory Effect of a Lysophosphatidic Acid 2 Agonist on Allergen-Driven Airway Inflammation.
    Knowlden SA; Hillman SE; Chapman TJ; Patil R; Miller DD; Tigyi G; Georas SN
    Am J Respir Cell Mol Biol; 2016 Mar; 54(3):402-9. PubMed ID: 26248018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of lysolipids on steroid synthesis in cells expressing endogenous LPA2 receptor.
    Budnik LT; Brunswig-Spickenheier B
    J Lipid Res; 2005 May; 46(5):930-41. PubMed ID: 15716590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysophosphatidic acid induces the migration and invasion of SGC-7901 gastric cancer cells through the LPA2 and Notch signaling pathways.
    Ren Z; Zhang C; Ma L; Zhang X; Shi S; Tang D; Xu J; Hu Y; Wang B; Zhang F; Zhang X; Zheng H
    Int J Mol Med; 2019 Jul; 44(1):67-78. PubMed ID: 31115486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.